Myasthenia Gravis Trial, Recruiting NCT07146425 Sponsor: Huashan Hospital Condition: Myasthenia Gravis
Back to Myasthenia Gravis

Myasthenia Gravis Trial, Recruiting

NCT07146425
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Myasthenia Gravis (MG):

  • You have been officially diagnosed with myasthenia gravis and are 18 years of age or older.
  • Your myasthenia gravis has been graded by doctors on a standard scale (called MGFA class I–IV), or your symptoms are currently under control with treatment.
  • You are willing and able to sign a consent form and a privacy agreement.

For healthy participants:

  • You are a similar age to the myasthenia gravis participants in the trial.

Who may not be able to join:

For people with Myasthenia Gravis (MG):

  • Your myasthenia gravis is currently in a severe crisis stage (known as MGFA class V), making it difficult to complete the study assessments.
  • You have serious heart or lung problems that would make it difficult to take part in the study activities.
  • You have a mental health condition or memory/thinking difficulties that the trial team believes could affect your ability to participate.
  • You have any other significant health condition that is currently unstable or poorly controlled.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chongbo Zhao, Ph.D., Huashan Hospital

Phone: 0086-021-52888780

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Huashan Hospital
Registry
ClinicalTrials.gov
Start date
31 August 2023
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Descriptive Analysis and Comparison of Digital Phenotypic Data across Subgroups; Correlation Between Digital Evaluation Model and Quantitative Myasthenia Gravis (QMG) Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov